IMG Wealth Management Inc. Invests $28,000 in MiMedx Group, Inc. (NASDAQ:MDXG)

IMG Wealth Management Inc. acquired a new position in MiMedx Group, Inc. (NASDAQ:MDXG) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 2,916 shares of the company’s stock, valued at approximately $28,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Thompson Siegel & Walmsley LLC raised its stake in shares of MiMedx Group by 78.1% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 103,267 shares of the company’s stock worth $993,000 after buying an additional 45,271 shares in the last quarter. AlphaQuest LLC bought a new stake in shares of MiMedx Group in the 4th quarter worth $88,000. Argentarii LLC bought a new stake in shares of MiMedx Group in the 4th quarter worth $160,000. Raymond James Financial Inc. bought a new stake in shares of MiMedx Group in the 4th quarter worth $887,000. Finally, Proficio Capital Partners LLC acquired a new stake in shares of MiMedx Group during the fourth quarter worth $443,000. Institutional investors own 79.15% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Cantor Fitzgerald reissued an “overweight” rating and issued a $13.00 price target on shares of MiMedx Group in a research note on Thursday, February 27th.

Insider Activity

In related news, CAO William Frank Iv Hulse sold 81,446 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $7.80, for a total value of $635,278.80. Following the completion of the sale, the chief accounting officer now owns 494,774 shares of the company’s stock, valued at approximately $3,859,237.20. The trade was a 14.13 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Kimberly Maersk-Moller sold 4,106 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $7.89, for a total value of $32,396.34. Following the completion of the sale, the insider now directly owns 310,836 shares of the company’s stock, valued at approximately $2,452,496.04. The trade was a 1.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 142,259 shares of company stock worth $1,116,170 in the last 90 days. Company insiders own 1.30% of the company’s stock.

MiMedx Group Price Performance

NASDAQ MDXG opened at $8.04 on Tuesday. The stock’s 50-day moving average price is $8.44 and its two-hundred day moving average price is $7.83. The company has a current ratio of 4.10, a quick ratio of 3.53 and a debt-to-equity ratio of 0.10. The company has a market cap of $1.18 billion, a PE ratio of 14.62 and a beta of 1.97. MiMedx Group, Inc. has a 1 year low of $5.47 and a 1 year high of $10.14.

MiMedx Group (NASDAQ:MDXG) last issued its earnings results on Wednesday, February 26th. The company reported $0.07 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.07. The company had revenue of $92.91 million for the quarter, compared to the consensus estimate of $89.42 million. MiMedx Group had a return on equity of 26.21% and a net margin of 23.86%. On average, analysts predict that MiMedx Group, Inc. will post 0.3 EPS for the current year.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.